Major bleeding · patients with heart failure with sinus rhythm
Warfarin may leads to higher major bleeding eventsc compared with placebo or no treatment (low certainty).
1 finding from 1 review
Minor bleeding · patients with venous thromboembolism.
It is very uncertain whether 10 mg warfarin nomogram changes minor bleeding it is not major bleeding compared with 5 mg warfarin nomogram (very low certainty).
1 finding from 1 review
Major bleeding fall in hemoglobin of > 20 g/L or transfusion of 2 or more units of red cells · patients with venous thromboembolism.
10 mg warfarin nomogram showed no clear difference in major bleeding fall in hemoglobin of > 20 g/L or transfusion of 2 or… compared with 5 mg warfarin nomogram (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin probably leads to higher major bleeding events compared with aspirin (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin may leads to higher major bleeding events compared with clopidogrel (low certainty).
1 finding from 1 review
Major bleeding · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) showed no clear difference in major bleeding compared with warfarin (low certainty).
1 finding from 1 review
Major bleeding · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes major bleeding compared with variable dose warfarin (very low certainty).
1 finding from 1 review
Major bleeding · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes major bleeding compared with 1 mg warfarin (very low certainty).
1 finding from 1 review